Volver a Agenda
Session Chair(s)
Ira Charles Spector, PHD, MBA
Chief Executive Officer
SFA Therapeutics, Inc., United States
Learning Objective : Discuss how to identify potential sites that are more likely to enroll and retain patients, using predictive performance metrics; Describe how to change the site selection process to utilize these contemporary approaches; Explain what sponsors can do to help improve site performance.
Speaker(s)
Predicting Clinical Research Site Performance
Ira Charles Spector, PHD, MBA
SFA Therapeutics, Inc., United States
Chief Executive Officer
Mining the Mother Lode: Harnessing the Right Data and Metrics to Find the Best Sites for Your Study
Elisabeth Otto, MA
QuintilesIMS, United States
Product Manager, CTOS
Using a Data-Driven Approach at the Site Level During the Feasibility Process to Help Ensure a More Accurate Trial Outcome
Rebecca Little
Rx Trials, Inc, United States
Associate Director, Business Development
Site Perspective
Daniel M Ulrey, MBA
Midwest Clinical Support, Inc., United States
President and Chief Executive Officer
¿Tiene una cuenta?